Cargando…

Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma

Changes in expression of long non-coding RNAs (lncRNAs) in plasma exosomes can be useful for diagnosis of cancer patients. Here, we conducted a four-stage study to identify plasma exosome lncRNAs with diagnostic potential in esophageal squamous cell carcinoma (ESCC). First, plasma exosome lncRNA exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Zichen, Yu, Ao, Rong, Weiwei, He, Xiaofeng, Zen, Ke, Shi, Minke, Wang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425435/ https://www.ncbi.nlm.nih.gov/pubmed/32597791 http://dx.doi.org/10.18632/aging.103559

Ejemplares similares

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
por: zhang, Lan, et al.
Publicado: (2020)

The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis
por: Weng, Nuo-Qing, et al.
Publicado: (2020)

A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma
por: Mao, Yu, et al.
Publicado: (2018)

Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma
por: Zhu, Jiahao, et al.
Publicado: (2022)

Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma
por: Zheng, Ze-Jun, et al.
Publicado: (2022)

Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma
por: Zhang, Jinfeng, et al.
Publicado: (2022)

The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Yu, et al.
Publicado: (2020)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

PD-L1 lncRNA splice isoform promotes lung adenocarcinoma progression via enhancing c-Myc activity
por: Qu, Shuang, et al.
Publicado: (2021)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

Expression and Clinical Value of LncRNA GAPLINC in Esophageal Squamous Cell Carcinoma
por: Wang, Peng, et al.
Publicado: (2021)

A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma
por: Huang, Guo-Wei, et al.
Publicado: (2018)

Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer
por: Zhang, Zhe, et al.
Publicado: (2023)

Exosomal lncRNA LINC01711 facilitates metastasis of esophageal squamous cell carcinoma via the miR-326/FSCN1 axis
por: Xu, Mei-Ling, et al.
Publicado: (2021)

Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma
por: Zhao, Fangchao, et al.
Publicado: (2022)

A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
por: Li, Xiaomeng, et al.
Publicado: (2021)

LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
por: Xu, Yan, et al.
Publicado: (2019)

LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma
por: Li, Jiagen, et al.
Publicado: (2014)

Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma
por: Yu, Jun, et al.
Publicado: (2019)

lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma
por: Zhang, Shujun, et al.
Publicado: (2021)

A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
por: Zhang, Chaoqi, et al.
Publicado: (2020)

A seven-lncRNA signature for predicting Ewing’s sarcoma
por: Chen, Zhihui, et al.
Publicado: (2021)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

Analysis of the expression profile of serum exosomal lncRNA in breast cancer patients
por: Zhao, Xin, et al.
Publicado: (2021)

Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
por: Xu, Yan, et al.
Publicado: (2021)

A five-cuproptosis-related LncRNA Signature: predicting prognosis, assessing immune function & drug sensitivity in lung squamous cell carcinoma
por: Zhao, Hongtao, et al.
Publicado: (2023)

Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer
por: Liu, Yang, et al.
Publicado: (2022)

An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma
por: Peng, Wang, et al.
Publicado: (2023)

Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA
por: Kang, Min, et al.
Publicado: (2018)

Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma
por: Yan, Suzhen, et al.
Publicado: (2020)

BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients
por: Zhao, Rui-Hua, et al.
Publicado: (2016)

The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Yang, Haixiu, et al.
Publicado: (2017)

A Promising Esophageal Cancer Prognostic Signature of Ferroptosis-Related LncRNA to Predict Immune Scenery and Immunotherapy Response
por: Liu, Xiaoxiao, et al.
Publicado: (2021)

lncRNA expression signatures in response to enterovirus 71 infection
por: Yin, Zhixin, et al.
Publicado: (2013)

A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma
por: Liu, Guancheng, et al.
Publicado: (2018)

Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2021)

Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis
por: Zhang, Chunyu, et al.
Publicado: (2021)

Bioinformatics analysis of esophageal cancer unveils an integrated mRNA-lncRNA signature for predicting prognosis
por: Lan, Tian, et al.
Publicado: (2020)

Targeting LncRNA LLNLR-299G3.1 with antisense oligonucleotide inhibits malignancy of esophageal squamous cell carcinoma cells in vitro and in vivo
por: TIAN, LI, et al.
Publicado: (2023)

Identification of a 5-lncRNA-Based Signature for Immune Characteristics and Prognosis of Lung Squamous Cell Carcinoma and Verification of the Function of lncRNA SPATA41
por: Huan, Sheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v5dg2p7viogvurlhgtfg0mdfh8